Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2001 8
2002 7
2003 10
2004 7
2005 47
2006 145
2007 149
2008 150
2009 143
2010 152
2011 173
2012 176
2013 197
2014 187
2015 194
2016 210
2017 234
2018 239
2019 229
2020 235
2021 213
2022 228
2023 233
2024 100

Text availability

Article attribute

Article type

Publication date

Search Results

3,220 results

Results by year

Filters applied: . Clear all
Page 1
The JAK/STAT signaling pathway: from bench to clinic.
Hu X, Li J, Fu M, Zhao X, Wang W. Hu X, et al. Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1. Signal Transduct Target Ther. 2021. PMID: 34824210 Free PMC article. Review.
STAT proteins in cancer: orchestration of metabolism.
Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. Li YJ, et al. Nat Rev Cancer. 2023 Mar;23(3):115-134. doi: 10.1038/s41568-022-00537-3. Epub 2023 Jan 3. Nat Rev Cancer. 2023. PMID: 36596870 Review.
JAK-STAT pathway inhibitors in dermatology.
Miot HA, Criado PR, de Castro CCS, Ianhez M, Talhari C, Ramos PM. Miot HA, et al. An Bras Dermatol. 2023 Sep-Oct;98(5):656-677. doi: 10.1016/j.abd.2023.03.001. Epub 2023 May 23. An Bras Dermatol. 2023. PMID: 37230920 Free PMC article. Review.
JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
Erdogan F, Radu TB, Orlova A, Qadree AK, de Araujo ED, Israelian J, Valent P, Mustjoki SM, Herling M, Moriggl R, Gunning PT. Erdogan F, et al. J Cell Mol Med. 2022 Apr;26(7):2049-2062. doi: 10.1111/jcmm.17228. Epub 2022 Mar 1. J Cell Mol Med. 2022. PMID: 35229974 Free PMC article. Review.
Janus kinase inhibitors in autoimmune bullous diseases.
Huang D, Zhang Y, Kong L, Lu J, Shi Y. Huang D, et al. Front Immunol. 2023 Jul 10;14:1220887. doi: 10.3389/fimmu.2023.1220887. eCollection 2023. Front Immunol. 2023. PMID: 37492565 Free PMC article. Review.
3,220 results